Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMNICELL, INC.OMCL · Entity 4666 | Director | June 01, 2026 | June 03, 2026 |
| Viatris IncVTRS · Entity 3277 | Director | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMNICELL, INC.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,100 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 4,845 · Balance 70,100 F1: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.
Viatris Inc
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 165,230 |
Ending reported balance
After 2026-03-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-06 · Exercise / conversion · Acquired 23,660 · Balance 164,055 Row 2 · 2026-03-06 · Exercise / conversion · Acquired 1,175 · Balance 165,230 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-06 · Exercise / conversion · Disposed 23,660 · Balance 0 F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 15,890 |
Reported balance
After 2026-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-06 · Grant · Acquired 15,890 · Balance 15,890 F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-06 · Exercise / conversion · Disposed 1,174.4921 · Balance 0 F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mylan II B.V.
Report date November 16, 2020 · Filed November 18, 2020
Section 16 reporting ended · disclosed 2020-11-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-16 · Disposition to issuer · Disposed 58,295 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.72 · Expires 2024-04-11 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-11-16 · Disposition to issuer · Disposed 2,974 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4: These options vested on April 11, 2015. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $50.66 · Expires 2025-11-17 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-11-16 · Disposition to issuer · Disposed 2,603 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5: These options vested on May 1, 2016. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $46.27 · Expires 2026-02-17 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-11-16 · Disposition to issuer · Disposed 2,788 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6: These options vested on February 17, 2017. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.18 · Expires 2027-03-03 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-11-16 · Disposition to issuer · Disposed 2,928 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7: These options vested on March 3, 2018. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-16 · Disposition to issuer · Disposed 2,984 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8: These options vested on March 2, 2019. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $27.45 · Expires 2029-03-01 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-11-16 · Disposition to issuer · Disposed 4,352 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9: These options vested on March 2, 2020. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2030-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-11-16 · Disposition to issuer · Disposed 6,151 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10: These options will vest on March 2, 2021. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-11-16 · Disposition to issuer · Disposed 9,440 · Balance 0 F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).
F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.
F4: These options vested on April 11, 2015.
F5: These options vested on May 1, 2016.
F6: These options vested on February 17, 2017.
F7: These options vested on March 3, 2018.
F8: These options vested on March 2, 2019.
F9: These options vested on March 2, 2020.
F10: These options will vest on March 2, 2021.
F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.
F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 4,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001236452-26-000002 · form4-06032026_040609.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,100 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 15,890 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008882 · form4.xml · derivative · entry 5 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,890 Underlying: Common Stock · 15,890 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 1,174.4921 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008882 · form4.xml · derivative · entry 4 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,174.4921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 23,660 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008882 · form4.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,660 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008882 · form4.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 23,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008882 · form4.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:12 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015381 · form4-06032025_080630.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,255 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 18:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 23,660 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036587 · ownership.xml · derivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,660 Underlying: Common Stock · 23,660 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 772.8421 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034008 · ownership.xml · derivative · entry 4 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 772.8421 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2024 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2024 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 18,204 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034008 · ownership.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 4, 2025. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 4, 2025. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034008 · ownership.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 18,204 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034008 · ownership.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:03 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 12,000 | $47.30 | $567,638.40 |
DisclosureSEC source: 0001415889-24-029080 · form4-12122024_091242.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,427 F1 · price: The price reported in Column 4 is a weighted average price of $47.3032. The sold price range between $46.98 to $47.64. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:29 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014262 · form4-05232024_080501.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,427 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 20:17 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 18,204 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026651 · ownership.xml · derivative · entry 5 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,204 Underlying: Common Stock · 18,204 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2025. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2025. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:17 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 884.8005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026651 · ownership.xml · derivative · entry 4 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 884.8005 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 3, 2023 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 3, 2023 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:17 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 17,970 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026651 · ownership.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 3, 2024. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 3, 2024. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:17 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 885 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026651 · ownership.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:17 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 17,970 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026651 · ownership.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 21:26 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 115 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-012226 · form4-08142023_090805.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,284 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as Chair of the Audit Committee, pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 2,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008791 · form4-05252023_080523.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,169 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board member, pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 704.8417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007216 · doc4.xml · derivative · entry 5 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 704.8417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2022 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F4 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2022 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 19,608 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007216 · doc4.xml · derivative · entry 4 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2023. F3 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2023. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 705 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007216 · doc4.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 4 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 19,608 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007216 · doc4.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 17,970 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007216 · doc4.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,970 Underlying: Common Stock · 17,970 shares Expires not disclosed F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs will vest on March 3, 2024. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs will vest on March 3, 2024. Read SEC document |
| December 28, 2022 Filed Dec 29, 2022 21:17 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001415889-22-013063 · form4-12292022_091221.xml · derivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a cash exercise of options. No sales of the Issuer's common stock have occurred as part of this transaction. Read SEC document |
| December 28, 2022 Filed Dec 29, 2022 21:17 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 3,000 | $14.87 | $44,610.00 |
DisclosureSEC source: 0001415889-22-013063 · form4-12292022_091221.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a cash exercise of options. No sales of the Issuer's common stock have occurred as part of this transaction. Read SEC document |
| December 22, 2022 Filed Dec 22, 2022 21:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001415889-22-012953 · form4-12222022_091213.xml · derivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a cash exercise of options. No sales of the Issuer's common stock have occurred as part of this transaction. Read SEC document |
| December 22, 2022 Filed Dec 22, 2022 21:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 3,000 | $14.87 | $44,610.00 |
DisclosureSEC source: 0001415889-22-012953 · form4-12222022_091213.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a cash exercise of options. No sales of the Issuer's common stock have occurred as part of this transaction. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001415889-22-012721 · form4-12192022_091233.xml · derivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 3,000 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a cash exercise of options. No sales of the Issuer's common stock have occurred as part of this transaction. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 3,000 | $14.87 | $44,610.00 |
DisclosureSEC source: 0001415889-22-012721 · form4-12192022_091233.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a cash exercise of options. No sales of the Issuer's common stock have occurred as part of this transaction. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:02 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001415889-22-012335 · form4-12092022_101248.xml · derivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 3,000 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a cash exercise of options. No sales of the Issuer's common stock have occurred as part of this transaction. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:02 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 3,000 | $14.87 | $44,610.00 |
DisclosureSEC source: 0001415889-22-012335 · form4-12092022_101248.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a cash exercise of options. No sales of the Issuer's common stock have occurred as part of this transaction. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 21:37 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 1,278 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001415889-22-011885 · form4-12012022_091232.xml · derivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 1,278 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option exercised and held in the account. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 21:37 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 1,278 | $14.87 | $19,003.86 |
DisclosureSEC source: 0001415889-22-011885 · form4-12012022_091232.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option exercised and held in the account. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:30 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 1,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005694 · form4-05262022_010549.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,181 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board member, pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2023 Annual Meeting of Stockholders. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:07 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001179110-22-002639 · edgar.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,278 Underlying: Common Stock · 2,000 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option Exercised and held in the account. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:07 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 2,000 | $14.87 | $29,740.00 |
DisclosureSEC source: 0001179110-22-002639 · edgar.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option Exercised and held in the account. F1 · price: Option Exercised and held in the account. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 20:15 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001179110-22-002420 · edgar.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,278 Underlying: Common Stock · 2,000 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option Exercised and held in the account. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 20:15 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 2,000 | $14.87 | $29,740.00 |
DisclosureSEC source: 0001179110-22-002420 · edgar.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option Exercised and held in the account. F1 · price: Option Exercised and held in the account. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 165.5224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011986 · doc4.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 165.5224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F2 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 165.5224 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011986 · doc4.xml · derivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165.5224 Underlying: Common Stock · 165.5224 shares Expires not disclosed F2 · derivative.exercise_price: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F2 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F2 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011986 · doc4.xml · nonDerivative · entry 1 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 22:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001179110-22-002153 · edgar.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,278 Underlying: Common Stock · 2,000 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option Exercised and held in the account. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 22:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 2,000 | $14.87 | $29,740.00 |
DisclosureSEC source: 0001179110-22-002153 · edgar.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option Exercised and held in the account. F1 · price: Option Exercised and held in the account. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 20:08 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 19,608 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009555 · doc4.xml · derivative · entry 5 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,608 Underlying: Common Stock · 19,608 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:08 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 334.4826 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009555 · doc4.xml · derivative · entry 4 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 334.4826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs. F3 · derivative.expiration_date: Represents dividend equivalent units that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:08 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 13,996 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009555 · doc4.xml · derivative · entry 3 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,996 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:08 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009555 · doc4.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.